STOCK TITAN

Zeo ScientifiX shifts fiscal year to June 30

Zeo ScientifiX, Inc. is shifting its fiscal year end to June 30, creating an eight-month transition period that will be reported on Form 10-KT.

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Zeo ScientifiX, Inc. (ZEOX) has changed its fiscal year end from October 31 to June 30, effective for the fiscal year ending June 30, 2026. This change was approved by the Board of Directors and became effective on September 10, 2026.

The transition period created by this change is the eight-month period from November 1, 2025 through June 30, 2026. Zeo ScientifiX plans to file a transition report on Form 10-KT covering this transition period, within the time period required by applicable Securities and Exchange Commission rules.

Positive

  • None.

Negative

  • None.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Prior fiscal year end October 31 Previous fiscal year end date before the change approved on September 10, 2026
New fiscal year end June 30 New fiscal year end for the fiscal year ending June 30, 2026
Transition period length 8 months From November 1, 2025 through June 30, 2026
Transition period start November 1, 2025 Beginning of the transition period created by the fiscal year change
Transition period end June 30, 2026 End of the transition period to be covered by Form 10-KT
Board approval date September 10, 2026 Date the Board of Directors approved the fiscal year end change
fiscal year end financial
"approved a change in the Company’s fiscal year end from October 31 to June 30"
transition period financial
"The transition period resulting from the change in fiscal year end is the eight-month period"
Form 10-KT regulatory
"The Company will file a transition report on Form 10-KT covering the transition period"
Form 10-KT is a U.S. Securities and Exchange Commission filing that provides an annual report covering a company’s transition period when it changes its fiscal year-end. Think of it like a shortened, catch-up yearbook that shows financial results and disclosures for the interim span between old and new reporting calendars; investors use it to understand performance across that irregular period and to compare trends consistently.
emerging growth company regulatory
"Emerging growth company As used in this"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What fiscal year change did Zeo ScientifiX, Inc. (ZEOX) announce?

Zeo ScientifiX, Inc. changed its fiscal year end from October 31 to June 30, effective for the fiscal year ending June 30, 2026. This adjustment alters the company’s standard annual reporting period going forward.

When is the new fiscal year end for ZEOX effective?

The new fiscal year end of June 30 is effective for Zeo ScientifiX, Inc. for the fiscal year ending June 30, 2026. The Board of Directors approved this change effective September 10, 2026.

What is the transition period caused by ZEOX’s fiscal year change?

The fiscal year change creates an eight-month transition period for Zeo ScientifiX, Inc. running from November 1, 2025 through June 30, 2026, which bridges the old and new fiscal year ends.

What special report will Zeo ScientifiX, Inc. file due to the fiscal year change?

Zeo ScientifiX, Inc. will file a transition report on Form 10-KT covering the eight-month period from November 1, 2025 through June 30, 2026, within the time frame required by Securities and Exchange Commission rules.

On what date did the Board approve ZEOX’s fiscal year end change?

The Board of Directors of Zeo ScientifiX, Inc. approved the fiscal year end change on September 10, 2026. The change shifts the year end from October 31 to June 30 for the fiscal year ending June 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false --10-31 0001557376 0001557376 2026-09-10 2026-09-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): September 10, 2026

 

ZEO SCIENTIFIX, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   000-55008   47-4180540
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

3321 College Avenue, Suite 246
Davie, Florida

  33314
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (888) 963-7881

 

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
None   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

As used in this Current Report on Form 8-K (this “Report”), and unless otherwise indicated, the terms “the Company,” “ZEO,” “we,” “us” and “our” refer to Zeo ScientifiX, Inc.

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

Effective September 10, 2026, the Board of Directors of the Company approved a change in the Company’s fiscal year end from October 31 to June 30, effective for the fiscal year ending June 30, 2026.

 

The transition period resulting from the change in fiscal year end is the eight-month period from November 1, 2025 through June 30, 2026.

 

The Company will file a transition report on Form 10-KT covering the transition period from November 1, 2025 through June 30, 2026, within the time period required by applicable rules of the Securities and Exchange Commission.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: September 15, 2026 ZEO SCIENTIFIX, INC.
     
  By: /s/ Ian T. Bothwell
   

Ian T. Bothwell

Chief Executive Officer and Chief Financial Officer

 

2

Filing Exhibits & Attachments

3 documents

Keep reading